An observational study in Posttraumatic Stress Disorder, sponsored by Rush University Medical Center. Terminated at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-18.
Sponsored by Rush University Medical Center · Observational
The aim of the project is to advance our understanding of how individuals with Posttraumatic Stress Disorder (PTSD) experience symptoms in their every-day lives when they are in their home environment. To date, all PTSD assessments are retrospective; individuals with PTSD are asked to recount and report their symptoms over the past weeks or months. Such assessment procedures are negatively impacted by individuals' abilities to accurately recall information. Moreover, retrospective assessments provide little information about how symptoms are experienced in the moment and how these experiences then lead to other behaviors. The proposed project addresses these limitations by assessing PTSD symptoms and associated biological markers (e.g., sleep, heart rate, heart rate variability) in real-time by asking subjects to wear a smart device and complete brief surveys. Data will be collected from 50 individuals with PTSD and 20 healthy controls to help us better understand individuals' real-time experience with PTSD and lay the foundation to develop algorithms for possible in-the-moment interventions in the future.
1,148 studies on the registry are indexed under Stress Disorders, Traumatic; 108 are open to participants now.
This study's enrollment of 14 is below the median of 140 across 177 observational studies indexed under Stress Disorders, Traumatic.
Browse Stress Disorders, Traumatic studies →Rush University Medical Center is the lead sponsor of 394 studies on the registry; 61 are open to participants now.
Of its 30 completed or terminated interventional studies of FDA-regulated products, 25 (83%) have results posted.
Counted across the registry records on this site, refreshed daily.
Individuals who either present as a healthy control or are deemed to have PTSD by the CAPS
Inclusion Criteria for participants with PTSD: Individuals are eligible for the current study if they:
Exclusion Criteria for PTSD participants: Individuals are excluded from the current study if:
Inclusion Criteria for healthy controls:
Individuals are eligible for the current study if they:
Exclusion Criteria for healthy controls:
Individuals are excluded from the current study if they:
Device: Biostrap EVO Wristband
Device: Biostrap EVO Wristband
Participants in both groups will wear the Biostrap wearable device
Clinician Administered PTSD Scale for DSM-5
Clinician administered measure of PTSD
Time frame: Through study completion, average of 1 month
PTSD Checklist for DSM-5 Criteria
Self-report measure of PTSD
Time frame: Through study completion, average of 1 month
Plan to share: No
No publications or documents are linked to this record.
This study is terminated, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rush University Medical Center